Related Experiment Video
Updated: Apr 24, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Desferioximine induced Ototoxicity in Thalassemic patients
Dharam Vir1, N K Panda2, R K Marwaha3
1Speech and Hearing Unit, Post Graduate Institute of Medical Education & Research Chandigarh (160012), INDIA.
Background:
Thalassemia is a hereditary disorder requiring regular blood transfusion.
Purpose:
To determine hearing sensitivity in transfusion-dependent thalassemics who were receiving desferioximine and on oral iron chelation (desferioximine) therapy.
Methods:
26 patients with B-thelassemia in the age range of 5-22 years were enrolled in the thalassemia transfusion unit in the Advanced Pediatric Center of Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. The patients to be enrolled in this study were randomly selected.
Results:
It was observed that the hearing deteriorated in patients who were given injected desferioximine whereas it fell within normal limits in case of those who were given oral iron chelation therapy.
Concluson:
This study confirms the necessity of regular audiological monitoring during the course of the disease.
More Related Videos
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Related Concept Videos
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration